Reviewing pharmacogenetics to advance precision medicine for opioids L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad, DJ Müller Biomedicine & Pharmacotherapy 142, 112060, 2021 | 21 | 2021 |
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study F Islam, VS Marshe, L Magarbeh, BN Frey, RV Milev, CN Soares, ... Translational psychiatry 12 (1), 366, 2022 | 15 | 2022 |
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND‐1 Study L Magarbeh, C Hassel, M Choi, F Islam, VS Marshe, CC Zai, R Zuberi, ... Clinical Pharmacology & Therapeutics 114 (1), 88-117, 2023 | 5 | 2023 |
Evaluation of the impact of waterpipe tobacco smoke exposure on the activity and expression of rat hepatic CYP450: a pharmacokinetic study OY Alshogran, LS Magarbeh, KH Alzoubi, MI Saleh, OF Khabour Inhalation Toxicology 30 (13-14), 519-526, 2018 | 3 | 2018 |
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A … F Islam, L Magarbeh, SSM Elsheikh, S Kloiber, CW Espinola, V Bhat, ... The Canadian Journal of Psychiatry 69 (3), 183-195, 2024 | | 2024 |
Polygenic Risk Score Analysis of Antidepressant Treatment Response: Results From the CAN-BIND-1 Cohort D Mueller, L Magarbeh, F Islam, V Marshe, B Frey, R Milev, C Soares, ... NEUROPSYCHOPHARMACOLOGY 48, 238-238, 2023 | | 2023 |
W26. POLYGENIC RISK SCORE ANALYSIS OF ANTIDEPRESSANT TREATMENT RESPONSE: RESULTS FROM THE CAN-BIND-1 COHORT L Magarbeh, F Islam, S Elsheikh, V Marshe, SH Kennedy, DJ Mueller, ... European Neuropsychopharmacology 75, S117-S118, 2023 | | 2023 |
Pharmacogenetics of lethal opioid overdose: review of current evidence and preliminary results from a pilot study L Magarbeh, I Gorbovskaya, R Wells, R Jhirad, B Le Foll, DJ Müller Journal of personalized medicine 13 (6), 918, 2023 | | 2023 |
EFFECTS OF CYP2C19, CYP2D6, AND ABCB1 GENE VARIANTS ON ESCITALOPRAM AND ARIPIPRAZOLE TREATMENT-RELATED SEXUAL SIDE EFFECTS: RESULTS FROM THE CAN-BIND-1 STUDY F Islam, L Magarbeh, BN Frey, R Milev, CN Soares, S Parikh, F Placenza, ... European Neuropsychopharmacology 63, e166-e167, 2022 | | 2022 |
Pharmacogenetics of lethal opioid overdose: Study protocol and preliminary findings D Mueller, L Magarbeh, I Gorbovskaya, R Wells, R Jhirad, B Le Foll | | 2022 |
The 43rd Annual Meeting of the Canadian College of Neuropsychopharmacology, November 4, 2021Role of histone 3.3 lysine 27 methylation in conferring enduring stress … A Torres-Berrío, S Yap, D Baribeau, A Mahmud, F Vahid-Ansari, ... Journal of Psychiatry and Neuroscience 47 (3 Suppl 1), S1-S24, 2022 | | 2022 |
Pharmacogenetics of lethal opioid overdose L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad, R Wells, DJ Mueller JOURNAL OF PSYCHIATRY & NEUROSCIENCE 47 (3), S10-S11, 2022 | | 2022 |
P256. ABCB1 Gene Variants and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis Including Results From the CAN-BIND-1 Cohort L Magarbeh, M Choi, C Hassel, CC Zai, N Freeman, V Marshe, F Islam, ... Biological Psychiatry 91 (9), S191, 2022 | | 2022 |
Pharmacogenetics of Lethal Opioid Overdose L Magarbeh, I Gorbovskaya, B Le Foll, R Jhirad, J Kennedy, D Mueller Biological Psychiatry 89 (9), S137, 2021 | | 2021 |